NexImmune Announces Research Collaboration with National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)
NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune
Kristi Jones David Hafler Us Congress Exchange Commission Neximmune Inc Us National Institutes Of Health
Source: einnews.com